Abstract As previously reported, triacsin C, a selective inhibitor of acyl-CoA synthetase, inhibited the synthesis of cholesteryl ester and triacylglycerol in mouse peritoneal macrophages, leading to a reduction of lipid droplets. Therefore, the in vivo efficacy was studied. Low-density lipoprotein receptor-knockout (LDLR Ϫ/Ϫ ) mice were fed a high cholesterol diet (0.15%) for two months to measure the atherogenic areas of the hearts and aortas. When triacsin C was orally administered (10 mg/kg/day), the atherosclerotic areas were significantly reduced by 86% in aorta and 36% in hearts. The results strongly suggested that triacsin C shows anti-atherogenic activity by inhibiting acyl-CoA synthetase activity.
Introduction
In the early stage of atherosclerosis, macrophages penetrate into the intima, efficiently take up modified low density lipoprotein (LDL), store cholesterol and fatty acid as the respective forms of cholesteryl ester (CE) and triacylglycerol (TG) in cytosolic lipid droplets, and are converted to foam cells, leading to the development of atherosclerosis in the arterial wall. Therefore, inhibitors of macrophage lipid droplet formation would be expected to retard the progression of atherosclerosis [1ϳ4] .
A cell-based assay was established to observe lipid droplet formation using primary mouse peritoneal macrophages [5] as a model of macrophage-derived foam cell formation in the artery. When macrophages are cultured with phosphatidylserine-containing liposomes, the liposomes are recognized by scavenger receptors and metabolized in a way similar to the natural ligand-modified LDL [6] , resulting in the accumulation of lipid droplets in the cytosol. In the morphological assays, lipid droplet formation was observed microscopically after staining lipid droplets with oil red O. In the biochemical assay, the amounts of [ 14 [7] . Triacsins A to D were isolated from the culture filtrate of Streptomyces sp. SK-1894 and consisted of 11-carbon alkenyl chains with a common triazenol moiety at their termini [8, 9] . On the basis of its unique target of inhibition, triacsins have been utilized in many studies to investigate the function of ACS in lipid metabolism [5, 10ϳ13] . These findings prompted us to study the in vivo efficacy of triacsins in an atherosclerogenic mouse model. In this study, we show anti-atherosclerotic activity of triacsin C in LDLR Ϫ/Ϫ mice.
Materials and Methods

Materials
Triacsin C ( Fig. 1 ) was purified from a culture broth of Streptomyces sp. SK-1894 by an established method [9] . Oil red O was purchased from SIGMA. Sudan IV was obtained from Wako Pure Chemical Industries (Osaka, Japan). Low-density lipoprotein receptor-knockout (LDLR Ϫ/Ϫ ) mice on a C57BL/6 background were purchased from The Jackson Laboratory (ME, USA).
In Vivo Anti-atherosclerotic Activity LDLR Ϫ/Ϫ mice were treated as previously described [14] .
Eight-week old mice were fed 0.15% cholesterolsupplemented diets (CLEA Japan, Tokyo, Japan), and 0.05% sodium carboxy methyl cellulose with or without triacsin C (10 mg/kg of body weight) was administered orally every day for two months. Blood was collected from the retroorbital venous plexus at zero, one, and two months. The levels of glucose, total cholesterol, TG, and free fatty acid in plasma were measured using an Advantage II (Roche Diagnostics), Determiner TC555 kit (Kyowa Medex, Tokyo, Japan), Triglyceride G-test kit (Wako Pure Chemicals, Osaka, Japan), and NEFA C-test kit (Wako Pure Chemicals), respectively. For atherosclerotic lesion analyses, whole aortas were stained with Sudan IV, and cross sections of the proximal aorta were prepared and stained with oil red O. The hearts were perfused with phosphate-buffered saline containing 3.0% formalin, were embedded in OCT compound (Sakura Tissue-Tek, Tokyo, Japan), and 6-mm-thick serial sections were cut by using a Cryostat (Leica, Tokyo, Japan). Four sections, each separated by 60 m m, were counter-stained with oil red O and hematoxylin and used to evaluate the lesions. Images of the sections were captured with a digital camera (CoolSnap Photometrics, Olympus, Tokyo, Japan) mounted on a light microscope (Vanox-S model, Olympus). Image analysis was performed by using Photoshop 6.0 software (Adobe).
Results and Discussion
After two-month feeding with a high cholesterol diet, LDLR Ϫ/Ϫ mice developed atherosclerotic lesions in the aortas and the hearts ( Fig. 2A and 2C , respectively). The atherosclerotic area was calculated to be 6.27% in the aortas and 10.2 m m 2 in the hearts. When triacsin C was administered orally (10 mg/kg/day) for two months, the atherosclerotic areas decreased to 0.90% (PϽ0.05) in the aortas (Fig. 2B) and to 6.5 mm 2 (PϽ0.05) in the hearts (Fig.  2D) , indicating 86% (Fig. 2E ) and 36% reduction (Fig. 2F) , respectively. The administration concentration of triacsin C (10 mg/kg/day) was set up by referring to the case of beauveriolides I and III. They inhibited the accumulation of CE in mouse peritoneal macrophages with IC 50 values of 0.78 and 0.41 m M, respectively, and exerted antiatherosclerotic activity by administering 25ϳ50 mg/kg/day under the same conditions [14] . There were no significant differences in the levels of glucose, total cholesterol and free fatty acid in the plasma during the two-month experiments, while the TG levels decreased to 70% of the control on day 60 (Fig. 3) . Nestel et al. reported that cis-9,trans-11 isomer of conjugated linoleic acid reduced plasma TG but did not suppress aortic atherosclerosis [16] . Furthermore, triacsin C showed no toxic effects on various tissues such as adrenal tissues and livers, showed no diarrhea in mice, and only a slight weight loss was observed (Fig. 4) .
It might be that triacsin C, an ACS inhibitor, directly affects macrophage-derived foam cell formation in the aortas and hearts of LDL Ϫ/Ϫ mice by inhibition of CE and TG synthesis in macrophages. Furthermore, triacsin C was reported to show anti-atherogenic activity to affect the several atherogenic factors. Triacsin C was reported to inhibit the generation of nitric oxide and superoxide anion [13, 18] , to induce the downregulation of leptin [19, 20] and the hydrolysis of TG [21] , and to inhibit the secretion of apolipoprotein B [22, 23] . We considered that the accumulation of these several effect induced the suppression of atherosclerosis. 
